Cost-effectiveness analyses.
Clark
C M
CM
D000924:Anticholesteremic Agents / Q000191:economics; D003362:Cost-Benefit Analysis; D004358:Drug Therapy / Q000191:economics*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics; D006937:Hypercholesterolemia / Q000188:drug therapy; D011322:Primary Prevention / Q000191:economics; D019057:Quality-Adjusted Life Years
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors